| 000 | 01268 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511201449.0 | ||
| 264 | 0 | _c19910415 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0165-1781 | ||
| 024 | 7 |
_a10.1016/0165-1781(90)90001-l _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeikkilä, L | |
| 245 | 0 | 0 |
_aDynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients. _h[electronic resource] |
| 260 |
_bPsychiatry research _cDec 1990 |
||
| 300 |
_a229-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aClopenthixol _xtherapeutic use |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDynorphins _xcerebrospinal fluid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aSchizophrenia _xcerebrospinal fluid |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 |
_aSubstance P _xcerebrospinal fluid |
| 700 | 1 | _aRimón, R | |
| 700 | 1 | _aTerenius, L | |
| 773 | 0 |
_tPsychiatry research _gvol. 34 _gno. 3 _gp. 229-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0165-1781(90)90001-l _zAvailable from publisher's website |
| 999 |
_c1712497 _d1712497 |
||